Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Arrowhead Pharmaceuticals (A2RR34.SA) Q3 2024 Earnings
A2RR34.SA
8
Aug
Confirmed
Q4 2023
Q1 2024
Q2 2024
Q3 2024
-9.42
-7.09
-4.76
-2.43
Details
Expected EPS
-2.9334820347000004
Actual EPS
-7.653618
Surprise EPS
-4.72
Surprise Percent
+160.91%
Description
Arrowhead Pharmaceuticals (A2RR34.SA) has reported earnings of -7.653618 per share for Q3 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login